# Pulmonx Corp financial performance 2026

> Live situation record from CLSTR: https://clstr.news/situations/pulmonx-corp-financial-performance-2026
> Updated: 2026-07-29T20:05:00.000Z. Sources: 7. Developments: 2.

After a 49 % drop in short interest in mid‑July, Pulmonx Corp saw hedge funds increase their stakes while its share price hovered near $1.25. The company’s Q2 2026 earnings were released on July 29, confirming earlier guidance. Worldwide revenue was $22.8 million, a 5 % year‑over‑year decline, with U.S. sales falling 4 % to $14.2 million and international revenue decreasing 6 % to $8.6 million, primarily because of no sales in China. Excluding China, overseas revenue rose 12 %. The quarter delivered a record gross margin of 78 % and trimmed the net loss by roughly one‑third (34 % versus the prior year), producing earnings per share of –$0.24, which beat consensus estimates. Shares remained flat around $1.25 and the CEO reiterated confidence in returning to revenue growth. The earnings release was noted alongside other market updates, such as Barclays raising its price target for Blue Owl Capital.

## Timeline

### 2026-07-29: Barclays lifts Blue Owl Capital price target to $10 as peers report earnings

Barclays raised Blue Owl Capital’s target to $10; Pulmonx Q2 2026 revenue fell 5% to $22.8 M with record margins; Canada Goose reported Q1 2027 results in a webcast earnings call.

6 sources. https://clstr.news/cluster/pulmonx-q2-2026-revenue-declines-in-us-and-international-markets

### 2026-07-13: Pulmonx Corp short interest falls 49% and schedules Q2 2026 earnings release

Pulmonx Corp short interest fell 49% in June, its stock dropped 3.4% to $1.43, and the company will release Q2 2026 earnings on July 29.

2 sources. https://clstr.news/cluster/pulmonx-corp-short-interest-falls-49-and-schedules-q2-2026-earnings-release

---
Cite as: Pulmonx Corp financial performance 2026. CLSTR, https://clstr.news/situations/pulmonx-corp-financial-performance-2026